Abbott & MSD ink strategic pact to distribute innovative oral anti-diabetic medicines in India
Abbott and MSD Pharmaceuticals, tradename of Merck & Co., Inc., Rahway, New Jersey, USA have inked a strategic collaboration through a distribution agreement for MSD’s oral anti-diabetic medicine, sitagliptin, its combination, sitagliptin/metformin …